{"entity":{"type":"insider","cik":"0001766524","url":"/insider/0001766524","json_url":"/insider/0001766524.json","name":"Koenig Sheldon L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":15,"first":"2022-03-18","last":"2026-06-18","span_basis":"filed_date"},"name_variants":[{"name":"Koenig Sheldon L.","source":"filing","n_filings":15,"first_seen":"2022-03-18","last_seen":"2026-06-18"}],"transactions":[{"id":5872928,"accession":"0001628280-26-044266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-044266","line_url":"/filing/0001628280-26-044266#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53588.0,"shares_display":"53,588","price_per_share":3.155,"price_display":"3.16","price_state":"stated","total_value":169070.14,"total_display":"169,070.14","total_whole":"169,070","shares_owned_after":2119111.0,"shares_owned_after_display":"2,119,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-18","scope":"insider"},{"id":5884701,"accession":"0001628280-26-019411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-019411","line_url":"/filing/0001628280-26-019411#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25578.0,"shares_display":"25,578","price_per_share":2.719,"price_display":"2.72","price_state":"stated","total_value":69546.582,"total_display":"69,546.58","total_whole":"69,547","shares_owned_after":2172699.0,"shares_owned_after_display":"2,172,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-18","scope":"insider"},{"id":4353284,"accession":"0001628280-25-057944","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-057944","line_url":"/filing/0001628280-25-057944#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48244.0,"shares_display":"48,244","price_per_share":3.673,"price_display":"3.67","price_state":"stated","total_value":177200.212,"total_display":"177,200.21","total_whole":"177,200","shares_owned_after":1470587.0,"shares_owned_after_display":"1,470,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-18","scope":"insider"},{"id":4481561,"accession":"0001766524-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001766524-25-000004","line_url":"/filing/0001766524-25-000004#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28427.0,"shares_display":"28,427","price_per_share":2.788,"price_display":"2.79","price_state":"stated","total_value":79254.476,"total_display":"79,254.48","total_whole":"79,254","shares_owned_after":1518831.0,"shares_owned_after_display":"1,518,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-18","scope":"insider"},{"id":4504009,"accession":"0001628280-25-032218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-032218","line_url":"/filing/0001628280-25-032218#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30474.0,"shares_display":"30,474","price_per_share":1.109,"price_display":"1.11","price_state":"stated","total_value":33795.666,"total_display":"33,795.67","total_whole":"33,796","shares_owned_after":1541488.0,"shares_owned_after_display":"1,541,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-18","scope":"insider"},{"id":4351892,"accession":"0001628280-25-013810","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-013810","line_url":"/filing/0001628280-25-013810#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13047.0,"shares_display":"13,047","price_per_share":1.504,"price_display":"1.50","price_state":"stated","total_value":19622.688,"total_display":"19,622.69","total_whole":"19,623","shares_owned_after":1571962.0,"shares_owned_after_display":"1,571,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-19","scope":"insider"},{"id":3269597,"accession":"0001628280-24-051868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-051868","line_url":"/filing/0001628280-24-051868#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12447.0,"shares_display":"12,447","price_per_share":2.466,"price_display":"2.47","price_state":"stated","total_value":30694.302,"total_display":"30,694.30","total_whole":"30,694","shares_owned_after":739819.0,"shares_owned_after_display":"739,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-18","scope":"insider"},{"id":2364776,"accession":"0001628280-24-040787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-040787","line_url":"/filing/0001628280-24-040787#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14550.0,"shares_display":"14,550","price_per_share":1.796,"price_display":"1.80","price_state":"stated","total_value":26131.8,"total_display":"26,131.80","total_whole":"26,132","shares_owned_after":752266.0,"shares_owned_after_display":"752,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-18","scope":"insider"},{"id":8690207,"accession":"0001628280-23-017231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-017231","line_url":"/filing/0001628280-23-017231#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.2596,"price_display":"1.26","price_state":"stated","total_value":25192.0,"total_display":"25,192.00","total_whole":"25,192","shares_owned_after":312816.0,"shares_owned_after_display":"312,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-10","scope":"insider"},{"id":8408463,"accession":"0001628280-23-008610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-008610","line_url":"/filing/0001628280-23-008610#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6999.0,"shares_display":"6,999","price_per_share":1.783,"price_display":"1.78","price_state":"stated","total_value":12479.217,"total_display":"12,479.22","total_whole":"12,479","shares_owned_after":292816.0,"shares_owned_after_display":"292,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-20","scope":"insider"},{"id":7935554,"accession":"0001628280-23-006991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-006991","line_url":"/filing/0001628280-23-006991#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5441.0,"shares_display":"5,441","price_per_share":5.056,"price_display":"5.06","price_state":"stated","total_value":27509.696,"total_display":"27,509.70","total_whole":"27,510","shares_owned_after":194815.0,"shares_owned_after_display":"194,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":6635315,"accession":"0001628280-22-025217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-025217","line_url":"/filing/0001628280-22-025217#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3394.0,"shares_display":"3,394","price_per_share":6.938,"price_display":"6.94","price_state":"stated","total_value":23547.572,"total_display":"23,547.57","total_whole":"23,548","shares_owned_after":198257.0,"shares_owned_after_display":"198,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-20","scope":"insider"},{"id":6792416,"accession":"0001628280-22-021568","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-021568","line_url":"/filing/0001628280-22-021568#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8606.0,"shares_display":"8,606","price_per_share":5.8041,"price_display":"5.80","price_state":"stated","total_value":49950.0846,"total_display":"49,950.08","total_whole":"49,950","shares_owned_after":198771.0,"shares_owned_after_display":"198,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-08","scope":"insider"},{"id":6103473,"accession":"0001628280-22-017642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-017642","line_url":"/filing/0001628280-22-017642#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4552.0,"shares_display":"4,552","price_per_share":4.991,"price_display":"4.99","price_state":"stated","total_value":22719.032,"total_display":"22,719.03","total_whole":"22,719","shares_owned_after":190165.0,"shares_owned_after_display":"190,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-21","scope":"insider"},{"id":6435336,"accession":"0001628280-22-006733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-006733","line_url":"/filing/0001628280-22-006733#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001766524","owner_name":"Koenig Sheldon L.","owner_display_name":"Koenig Sheldon L.","owner_url":"/insider/0001766524","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":571.0,"shares_display":"571","price_per_share":4.58,"price_display":"4.58","price_state":"stated","total_value":2615.18,"total_display":"2,615.18","total_whole":"2,615","shares_owned_after":194717.0,"shares_owned_after_display":"194,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Director, Officer (President and CEO)","n_filings":15,"first_seen":"2022-03-18","last_seen":"2026-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001766524","retrieved_at":"2026-08-23T17:28:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}